article thumbnail

At least three oncology 2023 brand launches have blockbuster potential

Pharmaceutical Technology

An analysis of GlobalData’s analyst consensus sales and forecast database reveals that three out of 12 novel oncology brands that launched globally from November 2022 to December 2023 have the potential to reach blockbuster sales.

Branding 130
article thumbnail

How brands can tap into wellness – lessons from influencers

Bio Pharma Dive

Our latest research uncovers new insights on how brands can truly close the wellness gap and grow within their industry sectors.

Branding 265
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How new technologies help keep brand planning simple

pharmaphorum

New technologies have revolutionised brand planning and strategy development, making it easier than ever to create and execute effective brand plans. Explore how these technologies simplify the brand planning process and maximise success.

Branding 100
article thumbnail

How to ensure brand planning success for 2024

pharmaphorum

Daniel Kohlstaedt, managing director at PurpleLeaf Strategy, discusses how new technologies can help pharmaceutical leaders plan for success during their upcoming brand planning cycle.

Branding 104
article thumbnail

Pharmanovia announces acquisition of Sanofi’s CNS brands

Pharmaceutical Technology

UK-based Pharmanovia has announced the acquisition of 11 central nervous system (CNS) brands from Sanofi.

Branding 130
article thumbnail

Nestlé Tops List of Most Valuable Food Brands in 2023

XTalks

Food giant Nestlé has once again claimed the top spot on the list of the world’s most valuable food brands in Brand Finance’s “Food & Drink 2023” report. To generate the report, Brand Finance conducted original market research on over 5,000 brands, covering 38 countries and 31 sectors.

Branding 105
article thumbnail

iNova to acquire Mundipharma’s consumer healthcare brands

Pharmaceutical Technology

iNova Pharmaceuticals has entered a deal to acquire a consumer healthcare brand portfolio from Mundipharma International.

Branding 130